Healthcare provider profile · identity verified

Jay Jonathan Virchow, MD

Internal Medicine · ELK GROVE VILLAGE, IL · NPI 1417931510

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	679	191
Lisinopril	Lisinopril	416	127
Levothyroxine Sodium	Levothyroxine Sodium	375	105
Rosuvastatin Calcium	Rosuvastatin Calcium	347	100
Amlodipine Besylate	Amlodipine Besylate	315	98
Losartan Potassium	Losartan Potassium	246	72
Metoprolol Succinate	Metoprolol Succinate	238	75
Metformin Hcl	Metformin Hcl	219	62
Simvastatin	Simvastatin	213	64
Hydrochlorothiazide	Hydrochlorothiazide	201	57
Omeprazole	Omeprazole	192	62
Pantoprazole Sodium	Pantoprazole Sodium	171	51
Tramadol Hcl	Tramadol Hcl	168	35
Tamsulosin Hcl	Tamsulosin Hcl	164	52
Alprazolam	Alprazolam	146	33
Gabapentin	Gabapentin	145	50
Metoprolol Tartrate	Metoprolol Tartrate	124	39
Sertraline Hcl	Sertraline Hcl	122	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	121	34
Montelukast Sodium	Montelukast Sodium	110	33
Allopurinol	Allopurinol	109	36
Duloxetine Hcl	Duloxetine Hcl	103	31
Escitalopram Oxalate	Escitalopram Oxalate	102	25
Eliquis	Apixaban	98	19
Zolpidem Tartrate	Zolpidem Tartrate	97	14
Furosemide	Furosemide	89	31
Glimepiride	Glimepiride	88	24
Meloxicam	Meloxicam	84	26
Jardiance	Empagliflozin	83	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	21
Fluticasone Propionate	Fluticasone Propionate	81	35
Pravastatin Sodium	Pravastatin Sodium	79	22
Clonazepam	Clonazepam	78	16
Ezetimibe	Ezetimibe	78	23
Albuterol Sulfate Hfa	Albuterol Sulfate	76	30
Prednisone	Prednisone	75	52
Potassium Chloride	Potassium Chloride	69	21
Atenolol	Atenolol	64	18
Citalopram Hbr	Citalopram Hydrobromide	63	16
Clopidogrel	Clopidogrel Bisulfate	63	20
Ozempic	Semaglutide	62	11
Quetiapine Fumarate	Quetiapine Fumarate	61	suppressed
Synthroid	Levothyroxine Sodium	60	17
Famotidine	Famotidine	59	16
Spironolactone	Spironolactone	58	17
Trazodone Hcl	Trazodone Hcl	55	12
Irbesartan	Irbesartan	54	16
Pioglitazone Hcl	Pioglitazone Hcl	54	19
Azithromycin	Azithromycin	52	43
Enalapril Maleate	Enalapril Maleate	49	12
Lorazepam	Lorazepam	49	11
Metformin Hcl Er	Metformin Hcl	45	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	18
Celecoxib	Celecoxib	40	17
Paxlovid	Nirmatrelvir/Ritonavir	39	39
Temazepam	Temazepam	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	suppressed
Xarelto	Rivaroxaban	39	12
Mounjaro	Tirzepatide	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	37	suppressed
Carvedilol	Carvedilol	37	14
Baclofen	Baclofen	36	suppressed
Alendronate Sodium	Alendronate Sodium	34	suppressed
Bupropion Xl	Bupropion Hcl	33	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Finasteride	Finasteride	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Meclizine Hcl	Meclizine Hcl	29	12
Mirtazapine	Mirtazapine	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	21
Buspirone Hcl	Buspirone Hcl	28	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Amoxicillin	Amoxicillin	27	18
Glipizide	Glipizide	27	suppressed
Naproxen	Naproxen	26	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	18
Azelastine Hcl	Azelastine Hcl	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	20
Bumetanide	Bumetanide	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Valsartan	Valsartan	20	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Diazepam	Diazepam	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Ramipril	Ramipril	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error